Science, regulation, and responsibility: Chemnovatic at GTNF 2025

The Global Tobacco and Nicotine Forum (GTNF) is the world’s leading annual conference discussing the future of the tobacco and nicotine industries. It serves as a global platform for the exchange of ideas and perspectives between public health experts, government representatives, the industry, and investors.

Founded in Rio de Janeiro in 2008, the GTNF was created to promote dialogue and cooperation, helping shape the future of nicotine policy through open discussion. Since then, the forum has traveled across continents, hosting meaningful conversations that connect science, regulation, and responsibility in the pursuit of a smoke-free future.

At GTNF 2025, policymakers, scientists, and industry leaders gathered once again to explore how to develop realistic, balanced, and evidence-based nicotine policies that align with rapid scientific progress.

Across multiple panels, one message echoed clearly: regulation must evolve as fast as science does.

While innovation in nicotine technologies – from advanced distillation methods to safer delivery systems – continues to move forward, many regulatory frameworks still struggle to keep pace, leading to unintended consequences such as illicit markets, unverified products, and reduced consumer safety.

Speakers at GTNF agreed that prohibition and over-restriction do not solve these challenges – instead, they often create new ones. The discussions therefore focused on building a global nicotine policy framework that is both effective and pragmatic – one that aims to minimize harm, not eliminate nicotine use entirely, recognizing its role in the transition away from combustible products.

Key takeaways included:

• evidence-based regulation informed by credible science
• supporting the shift to less harmful alternatives
• fair and proportional taxation to prevent illicit trade
• responsible communication and youth protection
• greater transparency and quality assurance throughout the supply chain

At GTNF 2025, Chemnovatic – represented by Tomasz Płaska, Head of Marketing, and Artur Skibicki, Head of Technology and R&D – took part in meaningful conversations with policymakers, scientists, and industry representatives – sharing perspectives on how evidence-based regulation and responsible manufacturing can truly support harm reduction. These discussions reflect our ongoing commitment to transparency, safety, and the responsible evolution of the nicotine industry.

As a European manufacturer of pure nicotine (PureNic99+), we believe that effective regulatory and tax frameworks should empower compliant, transparent producers who invest in quality, safety, and ethical business practices – rather than hinder responsible innovation.

By staying close to the global policy conversation and maintaining open dialogue with industry and public health representatives, Chemnovatic continues to advocate for practical, evidence-based harm reduction – contributing to a safer and more transparent nicotine market.

Tomasz Płaska Head of Marketing

Artur Skibicki Head of Technology and R&D

GTNF 2025 reaffirmed that the path forward for the nicotine sector lies in collaboration between science, regulation, and industry. Only through open dialogue can we create frameworks that protect consumers, foster innovation, and enable responsible growth.

At Chemnovatic, we are proud to contribute to this transformation – as a trusted partner delivering nicotine technologies that balance innovation with responsibility, driving progress toward a sustainable, smoke-free future.